Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CARA Cara Therapeutics	$0.66 -4.3%	$0.82	$0.50 ▼ $4.67	$36.13M	0.7	663,527 shs	350,693 shs
EIG Employers	$44.33 +2.9%	$44.33	$35.43 ▼ $46.78	$1.12B	0.24	134,313 shs	130,581 shs
MTY MTY Food Group	C$46.40 -0.5%	C$51.03	C$44.48 ▼ C$68.60	C$1.12B	1.98	51,029 shs	47,482 shs

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CARA Cara Therapeutics	-5.72%	-14.88%	-22.47%	+22.12%	-83.57%
EIG Employers	+1.39%	+0.75%	-2.86%	+5.20%	+1.08%
MTY MTY Food Group	-0.38%	-7.04%	-10.78%	-14.63%	-23.14%

Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CARA Cara Therapeutics	3.931 of 5 stars	3.4	2.0	0.0	4.2	2.0	1.7	1.3
EIG Employers	2.8022 of 5 stars	2.3	5.0	2.5	0.0	2.0	1.7	1.3
MTY MTY Food Group	3.3973 of 5 stars	3.2	0.0	1.7	0.0	1.6	2.5	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CARA Cara Therapeutics	2.75	Moderate Buy	$9.75	1,375.04% Upside
EIG Employers	2.50	Moderate Buy	$55.00	24.07% Upside
MTY MTY Food Group	2.43	Hold	C$54.29	17.00% Upside

Current Analyst Ratings

Latest MTY, EIG, JDW, MAB, and CARA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/16/2024	MTY MTY Food Group	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target		C$60.00 ➝ C$55.00
4/15/2024	MTY MTY Food Group	Acumen Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	C$75.00 ➝ C$65.00
4/15/2024	MTY MTY Food Group	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform	C$58.00 ➝ C$51.00
4/15/2024	MTY MTY Food Group	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Sector Perform	C$55.00 ➝ C$50.00
4/15/2024	MTY MTY Food Group	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform	C$62.00 ➝ C$53.00
4/15/2024	MTY MTY Food Group	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold	C$59.00 ➝ C$49.00
4/15/2024	MTY MTY Food Group	National Bankshares Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform	C$59.00 ➝ C$57.00
4/10/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/28/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
3/6/2024	CARA Cara Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$11.00 ➝ $10.00
3/5/2024	CARA Cara Therapeutics	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00

(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CARA Cara Therapeutics	$20.97M	1.72	N/A	N/A	$1.05 per share	0.63
EIG Employers	$850.90M	1.32	$5.10 per share	8.70	$39.42 per share	1.12
MTY MTY Food Group	C$1.16B	0.97	C$1.75 per share	26.52	C$33.45 per share	1.39

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CARA Cara Therapeutics	-$118.51M	-$2.18	N/A	N/A	N/A	-565.21%	-122.10%	-89.64%	5/20/2024 (Estimated)
EIG Employers	$118.10M	$4.47	9.92	11.98	N/A	13.88%	10.54%	2.82%	4/25/2024 (Confirmed)
MTY MTY Food Group	C$103M	C$4.25	10.92	∞	0.75	8.86%	13.23%	4.15%	7/9/2024 (Estimated)

Latest MTY, EIG, JDW, MAB, and CARA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/25/2024	N/A	EIG Employers	$0.69	N/A	-$0.69	N/A	N/A	N/A
4/12/2024	Q1 2024	MTY MTY Food Group	C$0.83	C$0.71	-C$0.12	C$0.71	C$263.20 million	C$278.64 million
3/4/2024	12/31/2023	CARA Cara Therapeutics	-$0.57	-$0.59	-$0.02	-$0.59	$2.34 million	$3.00 million
2/16/2024	Q4 2023	EIG Employers	$1.00	$1.40	+$0.40	$1.03	$215.38 million	$225.70 million
2/15/2024	Q4 2023	MTY MTY Food Group	C$0.99	C$0.67	-C$0.32	C$0.67	C$272.05 million	C$280.03 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CARA Cara Therapeutics	N/A	N/A	N/A	N/A	N/A
EIG Employers	$1.12	2.53%	+3.23%	25.06%	2 Years
MTY MTY Food Group	C$1.03	2.22%	N/A	24.24%	N/A

Latest MTY, EIG, JDW, MAB, and CARA Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/12/2024	MTY MTY Food Group	Quarterly	C$0.28	2.23%	5/2/2024	5/3/2024	5/15/2024
2/14/2024	EIG Employers	quarterly	$0.28	2.5%	2/27/2024	2/28/2024	3/13/2024
2/2/2024	MTY MTY Food Group	Quarterly	C$0.28	1.97%	2/2/2024	2/15/2024	2/15/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CARA Cara Therapeutics	N/A	4.54	4.43
EIG Employers	N/A	0.45	0.45
MTY MTY Food Group	154.98	0.61	0.57

Ownership

Institutional Ownership

Company	Institutional Ownership
CARA Cara Therapeutics	44.66%
EIG Employers	80.49%
MTY MTY Food Group	26.82%

Insider Ownership

Company	Insider Ownership
CARA Cara Therapeutics	4.20%
EIG Employers	1.40%
MTY MTY Food Group	16.15%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CARA Cara Therapeutics	55	54.66 million	52.36 million	Optionable
EIG Employers	717	25.34 million	24.99 million	Optionable
MTY MTY Food Group	7,326	24.17 million	N/A	Not Optionable

MTY, EIG, JDW, MAB, and CARA Headlines

Source	Headline
	Renee St-Onge Buys 325 Shares of MTY Food Group Inc. (TSE:MTY) Stock marketbeat.com - April 19 at 1:44 PM
	Tesla Layoffs, Canadian CPI and Jamie Dimon’s Warning ca.investing.com - April 18 at 7:49 PM
	FY2025 EPS Estimates for MTY Food Group Inc. (TSE:MTY) Boosted by National Bank Financial americanbankingnews.com - April 18 at 3:28 AM
	Research Analysts Issue Forecasts for MTY Food Group Inc.'s FY2025 Earnings (TSE:MTY) marketbeat.com - April 17 at 5:56 PM
	Should Investors Buy the Dip in MTY Stock? fool.ca - April 17 at 2:09 PM
	MTY Food Group (TSE:MTY) Given New C$55.00 Price Target at Raymond James americanbankingnews.com - April 17 at 4:22 AM
	MTY Food Group Inc. to Post Q2 2024 Earnings of $0.99 Per Share, Raymond James Forecasts (TSE:MTY) americanbankingnews.com - April 17 at 1:38 AM
	FY2024 EPS Estimates for MTY Food Group Inc. Cut by National Bank Financial (TSE:MTY) americanbankingnews.com - April 17 at 1:38 AM
	Raymond James Cuts MTY Food Group (TSE:MTY) Price Target to C$55.00 marketbeat.com - April 16 at 11:21 AM
	CIBC Keeps Their Buy Rating on MTY Food Group (MTYFF) markets.businessinsider.com - April 16 at 8:09 AM
	National Bank Financial Weighs in on MTY Food Group Inc.'s FY2024 Earnings (TSE:MTY) marketbeat.com - April 16 at 7:28 AM
	MTY Food Group (TSE:MTY) Given New C$57.00 Price Target at National Bankshares americanbankingnews.com - April 16 at 4:22 AM
	MTY Food Group (TSE:MTY) Price Target Cut to C$49.00 by Analysts at TD Securities americanbankingnews.com - April 16 at 3:50 AM
	MTY Food Group (TSE:MTY) Price Target Cut to C$53.00 by Analysts at CIBC americanbankingnews.com - April 16 at 3:50 AM
	MTY Food Group (TSE:MTY) Given New C$50.00 Price Target at Scotiabank americanbankingnews.com - April 16 at 3:50 AM
	MTY Food Group (TSE:MTY) Price Target Lowered to C$51.00 at Royal Bank of Canada americanbankingnews.com - April 16 at 3:50 AM
	MTY Food Group (TSE:MTY) Price Target Lowered to C$65.00 at Acumen Capital americanbankingnews.com - April 16 at 3:50 AM
	Don't Look Now But Food Courts Are In And These Brands Are Cashing In msn.com - April 15 at 6:09 PM
	Monday’s analyst upgrades and downgrades for April 15 theglobeandmail.com - April 15 at 7:40 AM
	MTY Food Group (TSE:MTY) Posts Earnings Results, Misses Expectations By $0.12 EPS americanbankingnews.com - April 15 at 7:08 AM
	MTY Food Group (TSE:MTY) Stock Price Down 7.9% After Earnings Miss americanbankingnews.com - April 14 at 1:42 AM
	MTY Food Group Inc. (MTYFF) Q1 2024 Earnings Call Transcript seekingalpha.com - April 14 at 1:14 AM
	MTY Food Group First Quarter 2024 Earnings: EPS: CA$0.71 (vs CA$0.75 in 1Q 2023) finance.yahoo.com - April 13 at 10:13 AM
	MTY Food Group Inc. Plans Quarterly Dividend of $0.28 (TSE:MTY) marketbeat.com - April 13 at 8:00 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 3, 2024 6:20 AM
View Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
April 9, 2024 6:07 AM
View Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out?
Home Depot vs. Lowe's: The Home Improvement Stocks Heavyweights
April 2, 2024 7:02 AM
View Home Depot vs. Lowe's: The Home Improvement Stocks Heavyweights
7 Stocks That Will Drive the Weight Loss Drugs Market
March 28, 2024 7:22 AM
View 7 Stocks That Will Drive the Weight Loss Drugs Market
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
April 18, 2024 10:20 AM
View CSX Co.: The Railroad Powering Ahead with an Earnings Beat

All Headlines

Company Descriptions

Cara Therapeutics

NASDAQ:CARA

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Employers

NYSE:EIG

Employers Holdings, Inc., through its subsidiaries, operates in the commercial property and casualty insurance industry primarily in the United States. The company operates in two segments, Employers and Cerity. It offers workers' compensation insurance to small businesses in low to medium hazard industries under the Employers and Cerity brands. The company markets its products through local, regional, and national agents and brokers; alternative distribution channels; and national, regional, and local trade groups and associations, as well as directly to customers. Employers Holdings, Inc. was founded in 2000 and is based in Henderson, Nevada.

MTY Food Group

TSE:MTY

MTY Food Group Inc. operates and franchises quick-service, fast-casual, and casual dining restaurants in Canada, the United States, and internationally. It also sells retail products under a multitude of banners. The company was formerly known as iNsu Innovations Group Inc. and changed its name to MTY Food Group Inc. in July 2003. MTY Food Group Inc. was founded in 1979 and is headquartered in Saint-Laurent, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial